iTeos Therapeutics, Inc. ITOS
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 121152 | 0 | 121152 | 121152 | 0 % | 21/11/2024 |
| BVF Inc. | Delaware | 0 | 2325000 | 0 | 2325000 | 2325000 | 6.4 % | 21/11/2024 |
| BVF Partners L.P. | Delaware | 0 | 2325000 | 0 | 2325000 | 2325000 | 6.4 % | 21/11/2024 |
| BVF GP Holdings LLC | Delaware | 0 | 2158450 | 0 | 2158450 | 2158450 | 5.9 % | 21/11/2024 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 121152 | 0 | 121152 | 121152 | 0 % | 21/11/2024 |
| BVF II GP LLC | Delaware | 0 | 964115 | 0 | 964115 | 964115 | 2.6 % | 21/11/2024 |
| Mark N. Lampert | United States | 0 | 2325000 | 0 | 2325000 | 2325000 | 6.4 % | 21/11/2024 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1194335 | 0 | 1194335 | 1194335 | 3.3 % | 21/11/2024 |
| BVF I GP LLC | Delaware | 0 | 1194335 | 0 | 1194335 | 1194335 | 3.3 % | 21/11/2024 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 964115 | 0 | 964115 | 964115 | 2.6 % | 21/11/2024 |
| BlackRock, Inc. | Delaware | 3572624 | 0 | 3882549 | 0 | 3882549 | 10.6 % | 08/11/2024 |
| BlackRock, Inc. | Delaware | 0 | 0 | 3882549 | 0 | 3882549 | 10.6 % | 21/10/2024 |
| Millennium Group Management LLC | Delaware | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Israel A. Englander | United States | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Millennium Group Management LLC | Delaware | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Millennium Management LLC | Delaware | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Israel A. Englander | United States | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Millennium Management LLC | Delaware | 0 | 967402 | 0 | 967402 | 967402 | 2.7 % | 09/01/2024 |
| Millennium Management LLC | Delaware | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Millennium Group Management LLC | Delaware | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Millennium Management LLC | Delaware | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Millennium Group Management LLC | Delaware | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Israel A. Englander | United States | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Israel A. Englander | United States | 0 | 2090833 | 0 | 2090833 | 2090833 | 5.8 % | 24/10/2023 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 975430 | 0 | 975430 | 975430 | 2.7 % | 13/02/2023 |
| BVF I GP LLC | Delaware | 0 | 975430 | 0 | 975430 | 975430 | 2.7 % | 13/02/2023 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 721705 | 0 | 721705 | 721705 | 2 % | 13/02/2023 |
| BVF II GP LLC | Delaware | 0 | 721705 | 0 | 721705 | 721705 | 2 % | 13/02/2023 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 85725 | 0 | 85725 | 85725 | 0 % | 13/02/2023 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 85725 | 0 | 85725 | 85725 | 0 % | 13/02/2023 |
| BVF GP Holdings LLC | Delaware | 0 | 1697135 | 0 | 1697135 | 1697135 | 4.8 % | 13/02/2023 |
| BVF Partners L.P. | Delaware | 0 | 1810835 | 0 | 1810835 | 1810835 | 5.1 % | 13/02/2023 |
| BVF Inc. | Delaware | 0 | 1810835 | 0 | 1810835 | 1810835 | 5.1 % | 13/02/2023 |
| Mark N. Lampert | United States | 0 | 1810835 | 0 | 1810835 | 1810835 | 5.1 % | 13/02/2023 |
| The Vanguard Group | Pennsylvania For | 0 | 30013 | 1767898 | 51132 | 1819030 | 5.11 % | 09/02/2023 |
| BlackRock, Inc. | Delaware | 0 | 0 | 0 | 0 | 4479421 | 12.6 % | 20/01/2023 |
| BlackRock, Inc. | Delaware | 3665596 | 0 | 3721237 | 0 | 3721237 | 10.5 % | 08/07/2022 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1041669 | 0 | 1041669 | 1041669 | 2.9 % | 02/05/2022 |
| BVF II GP LLC | Delaware | 0 | 767159 | 0 | 767159 | 767159 | 2.2 % | 02/05/2022 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 767159 | 0 | 767159 | 767159 | 2.2 % | 02/05/2022 |
| BVF I GP LLC | Delaware | 0 | 1041669 | 0 | 1041669 | 1041669 | 2.9 % | 02/05/2022 |
| Mark N. Lampert | United States | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| BVF Inc. | Delaware | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| BVF Partners L.P. | Delaware | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 1808828 | 0 | 1808828 | 1808828 | 5.1 % | 02/05/2022 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 91899 | 0 | 91899 | 91899 | 0 % | 02/05/2022 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 91899 | 0 | 91899 | 91899 | 0 % | 02/05/2022 |
| BVF II GP LLC | Delaware | 0 | 767159 | 0 | 767159 | 767159 | 2.2 % | 02/05/2022 |
| Mark N. Lampert | United States | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| Biotechnology Value Fund II, L.P. | Delaware | 0 | 767159 | 0 | 767159 | 767159 | 2.2 % | 02/05/2022 |
| BVF I GP LLC | Delaware | 0 | 1041669 | 0 | 1041669 | 1041669 | 2.9 % | 02/05/2022 |
| Biotechnology Value Fund, L.P. | Delaware | 0 | 1041669 | 0 | 1041669 | 1041669 | 2.9 % | 02/05/2022 |
| BVF Inc. | Delaware | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| BVF Partners L.P. | Delaware | 0 | 1929201 | 0 | 1929201 | 1929201 | 5.4 % | 02/05/2022 |
| BVF GP HOLDINGS LLC | Delaware | 0 | 1808828 | 0 | 1808828 | 1808828 | 5.1 % | 02/05/2022 |
| BVF Partners OS Ltd. | Cayman Islands | 0 | 91899 | 0 | 91899 | 91899 | 0 % | 02/05/2022 |
| Biotechnology Value Trading Fund OS LP | Cayman Islands | 0 | 91899 | 0 | 91899 | 91899 | 0 % | 02/05/2022 |
| RTW Investments, LP | Delaware | 0 | 2762791 | 0 | 2762791 | 2762791 | 7.88 % | 04/02/2021 |
| Roderick Wong | United States of America | 0 | 2762791 | 0 | 2762791 | 2762791 | 7.88 % | 04/02/2021 |
| RTW Master Fund, Ltd. | Cayman Islands | 0 | 1846704 | 0 | 1846704 | 1846704 | 5.27 % | 04/02/2021 |